Interscalene Nerve Block vs. Sedation for Shoulder Dislocation Reduction
Shoulder Dislocation, Brachial Plexus Block
About this trial
This is an interventional treatment trial for Shoulder Dislocation focused on measuring Shoulder dislocation reduction, Ultrasound guided interscalene block (ISCB), Sedation
Eligibility Criteria
Inclusion Criteria:
1. Patients (ASA SCORE I-III) without acute cardio-pulmonary decompensation, who arrive to the ER with shoulder dislocation for reduction maneuver.
Exclusion Criteria:
- Unconscious patient
- Patient refusal/unable to give informed consent
- Patients with acute cardio-pulmonary decompensation
- Patients with known allergy to medications which will be included in the study
- Patients who suffer additional injuries and need to be hospitalized for further treatment
- Patients who received narcotic/sedative premedication before the procedure
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Sedation
US guided ISCB
Analgesia and sedation through IV medication for pain relief will be administered to the patient. Midazolam: up to a maximum dosage of 0.1 mg/kg (bolus of 1 mg by titration every 30-60 second). Ketamine: up to maximum dosage of 100 mg IV (bolus of 25 mg by titration every 30-60 seconds).
Infiltration of local anesthetic agents around target nerves (C5, C6 nerve roots), US guidance, for shoulder pain relief and muscle relaxation. Lidocaine 2%: 15-20 ml.